Single Dose of SHR-1222, a Sclerostin Monoclonal Antibody, in Healthy Men and Postmenopausal Women With Low Bone Mass: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Phase I Study
发布时间：2023-10-17
点击次数：
发表刊物：Frontiers in Pharmacology
是否译文：否